Alyeska Investment Group
PRAH

Alyeska Investment Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Alyeska Investment Group’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-112,415
Closed -$11.2M – 521
2019
Q3 		$11.2M Buy
+112,415
New +$11.2M 0.16% 159
2017
Q4 		– Sell
-463,941
Closed -$35.3M – 560
2017
Q3 		$35.3M Buy
463,941
+49,693
+12% +$3.76M 0.26% 123
2017
Q2 		$31.1M Sell
414,248
-460,033
-53% -$31.9M 0.26% 130
2017
Q1 		$57M Buy
874,281
+191,196
+28% +$11.3M 0.46% 72
2016
Q4 		$37.7M Buy
683,085
+378,871
+125% +$20.8M 0.31% 118
2016
Q3 		$17.2M Buy
+304,214
New +$14.9M 0.16% 205
2015
Q1 		– Sell
-458,036
Closed -$11.1M – 611
2014
Q4 		$11.1M Buy
+458,036
New +$10.3M 0.19% 198

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Alyeska Investment Group's PRAH Position: Q4 2019 in Review

Alyeska Investment Group sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2019, closing a stake of 112,415 shares — an estimated $11.2M sold.

Alyeska Investment Group first reported a position in PRAH in Q4 2014 and held it in 7 quarters. The position peaked at $57M in Q1 2017. 345 funds tracked by Wall St. Rank hold PRAH as of Q4 2019.

  • Alyeska Investment Group reported no remaining PRA Health Sciences, Inc. position as of Q4 2019 after selling out during the quarter.
  • Alyeska Investment Group sold 112,415 PRA Health Sciences, Inc. shares in Q4 2019, an estimated $11.2M.
  • Alyeska Investment Group first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 7 quarters.
  • Alyeska Investment Group's PRA Health Sciences, Inc. position peaked at $57M in Q1 2017.
  • 345 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2019.

Based on Alyeska Investment Group's 13F filing for Q4 2019, filed 14 Feb 2020.